Life-Sciences

AI-Enhanced

Care Pathways

We are excited to enter into this collaboration with Qure to deliver tools that will streamline imaging-based tumor burden measurements, an important part of both clinical trials and routine care for cancer patients.

The autoRECIST program holds the promise of improving these processes and accelerating the delivery of lifesaving treatments to patients. We are very excited to be working with Qure.ai on this important project.

Jon McDunn, PhD

President , Project Data Sphere

“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”

Leif Johannsson

Chairman, AstraZeneca

“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."

Michael Blackwell

President and Managing Director, Medtronic India

"Our partnership with Qure.ai represents a critical step in our commitment to the EDISON Alliance's 1 Billion Lives Challenge. Lung cancer remains a major global health concern, and it is through applying AI to screen for lung cancer risk in millions of routine X-rays, that it will provide a low-cost, high-impact way of ensuring at-risk patients enter the right diagnostic and care pathway.

This milestone exemplifies our A.Catalyst Network approach to expanding access to digital healthcare and driving sustainable change in the communities we serve."

Nipun Jain

Head of International A.Catalyst Network, AstraZeneca

“In our quest to drive data-driven innovations in clinical oncology, the advancements made by Qure.ai stand out. Their AI tools, particularly in radiology, align perfectly with our mission at Project Data Sphere. By collaborating with partners like Qure.ai, we can catalyze innovative ideas and transform the landscape of oncology clinical trials.

Qure.ai's commitment to enhancing image analysis and assisting radiologists through AI is commendable and pivotal in accelerating clinical research and improving patient outcomes. Their work is a testament to the incredible potential of AI in revolutionizing healthcare.”

Asba Tasneem

Executive Director, Project Data Sphere

"The partnership between Medtronic and Qure.ai is a significant stride in revolutionizing stroke care in India. Integrating Qure.ai's AI solutions in our hub-and-spoke model is pivotal, with nearly two million people affected by stroke annually.

This collaboration enables rapid analysis of CT scans, facilitating timely treatment. It's remarkable how AI transforms stroke management, especially in regions where access to specialized care is challenging."

Prateek Tiwari

Senior Director of Neuroscience and Specialty Therapies, Medtronic

"Qure.ai’s contribution to stroke management in India, through its partnership with Medtronic, aligns perfectly with our mission at the World Stroke Organization. Their AI-enabled solutions are instrumental in addressing the challenges of stroke care, particularly in areas with limited neurologist availability.

This collaboration is vital in ensuring timely and accurate diagnosis and treatment of stroke patients, significantly impacting patient outcomes and reducing the burden of stroke in India."

Dr. Jeyaraj Pandian

President-Elect of the World Stroke Organization and Principal (Dean), CMC Ludhiana

"AI's integration into radiology, exemplified by Qure.ai, has proven to be a game-changer. It significantly extends the capabilities of our radiologists, enhancing their diagnostic accuracy and enabling them to identify illnesses and lesions with a level of precision previously unattainable.

Qure.ai's AI solutions are not just tools but partners in our quest for excellence in patient care, helping us detect critical health issues that might otherwise have been missed. This is more than innovation; it's a vital step forward in medical technology that promises to redefine patient outcomes."

Dr. Nazih Gharios

CEO, Mount Lebanon Hospital University Medical Center

Transforming Life Sciences with AI Innovation

Driving early diagnosis & treatment monitoring with AI

Transforming Healthcare with AI  

Qure.ai’s AI solutions are helping improve early disease detection via advanced biomarkers and incidental findings, enabling early enrolment into care pathways.

Collaborating to Enhance Outcomes

Qure's collaboration with leading pharma and medical device partners is enabling AI-powered care pathways with early patient diagnosis, efficient treatment monitoring and multi-stakeholder collaboration.

Personalizing Patient Care

Qure’s algorithms enable precise tracking of treatment efficacy, enabling tailored care pathways for individual patient needs, which improves treatment effectiveness and care quality.